BioSpace News Archive

Blueprint Medicines Corporation reported financial results and provided a business update for the quarter ended March 31, 2019.

Robust Clinical Evidence Supports PREVENATM Therapy Effectiveness in Reducing SSIs in a Range of Medical Specialties

Evergreen Pacific Insurance Corporation is pleased to announce its new partnership with Carbon Compounds Pharmacy

Financial Matters Expert to Serve as Chair of Audit Committee

Vivimed Life Sciences Pvt Ltd (Vivimed) is recalling 19 lots of Losartan Potassium Tablets USP 25 mg, 50 mg, and 100 mg to consumer level due to the detection of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), a possible process impurity or contaminant in an active pharmaceutical ingredient manufactured by Hetero Labs Limited (API manufacturer), that is above the US Food & Drug Administration’s interim acceptable exposure limit of 9.82 ppm.

Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education, will present the 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®. The conference will take place Nov. 6-8 at the New York Marriott Marquis in New York City.

The Avoca Group announced today that David Shing, Verizon Media’s Digital Prophet, will deliver the keynote address at the 8th Annual Avoca Global Summit.

The Asian medical cannabis market will be worth an estimated US$5.8 billion by 2024, the world’s leading market intelligence and strategic consultancy firm Prohibition Partners has found in its latest report.

LabShares Newton, a shared office and laboratory incubator for emerging biotechnology and life science companies, announced today that Savran Technologies is the winner of the first Launch@LabShares competition, providing a $50K year-long membership, including scientific and operational support, to this novel diagnostics startup.

A new clinical study shows that Natera’s Signatera™ test identified colorectal cancer recurrence up to 16.5 months earlier than radiologic imaging by detecting traces of tumor DNA in the blood after surgery.